Literature DB >> 15162983

Comparison of three different diuretic renal scintigraphy protocols in patients with dilated upper urinary tracts.

Seyda Türkölmez1, Tamer Atasever, Kadir Türkölmez, Orhan Gögüs.   

Abstract

PURPOSE: To compare 3 different diuretic renal scintigraphy protocols in patients with dilated upper urinary tract.
MATERIALS AND METHODS: Three diuresis renography protocols were performed in 22 adult patients (28 kidneys) with upper urinary tract dilatation. The diuretic was given 20 minutes after (F+20), at the same time as (F+0), and 15 minutes before (F-15) radionuclide administration. The mean age was 29.8 years (range, 18-43 years). The 3 protocols were identical, except for the time of injection of furosemide. The F+0 protocol could not be performed in 1 and F-15 in 2 of the patients. Each of the 3 protocols was performed for the rest of the patients. The results were classified as nonobstructive, equivocal, and obstructive according to the renogram images and curves.
RESULTS: None of the patients showed equivocal results in both F+0 and F-15 protocols. In the F+20 studies, 7 of the 28 kidneys were evaluated as equivocal. Of these, 5 kidneys showed nonobstructive and 2 kidneys revealed obstructive renogram patterns with the other 2 protocols (F+0 and F-15). Moreover, one kidney, which was evaluated as nonobstructive in the F+20 protocol, showed an obstructive pattern in both F+0 and F-15 protocols. All of the kidneys showing obstructive patterns in the F+20 study also revealed obstruction in the F+0 and F-15 investigations. We could not find any difference between the renogram patterns of F+0 and F-15 investigations.
CONCLUSIONS: F+0 and F-15 protocols allow clarification in cases of equivocal F+20 studies. Because the F+0 study is more practical and shorter, we suggest the F+0 method when equivocal results are obtained by an F+20 study or as a single test when there is only one opportunity to confirm or exclude the presence of obstruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162983     DOI: 10.1097/01.rlu.0000113852.57445.23

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

1.  The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children.

Authors:  Massoud Majd; Zvi Bar-Sever; Ana Isabel Santos; Diego De Palma
Journal:  J Nucl Med       Date:  2018-10       Impact factor: 10.057

2.  Insertion of double J stent as a therapeutic test in management of adults presenting with loin pain and equivocal ureteropelvic junction obstruction.

Authors:  Tarek Osman; Khaled Fawaz; Alaa Abdelmaksoud; Ihab Eltahawy; Wael Safa; Tarek El Zayat; Dahlia El Sadek; Rafik El Halaby
Journal:  World J Urol       Date:  2009-08-14       Impact factor: 4.226

3.  F+0 diuretic protocol is superior to F-15 and F+20 for nuclear renogram in children.

Authors:  Ramesh Babu; Dhandapani Venkatsubramaniam; Easwaramoorthy Venkatachalapathy
Journal:  Indian J Urol       Date:  2015 Jul-Sep

4.  Comparison of the F+20 and F-15 Diuresis Technetium-99m Diethylenetriaminepentacetate Renography Protocols for Diagnosis of Ureteropelvic Junction Obstruction in Adult Patients with Hydronephrosis.

Authors:  Majhi Tapas Kumar; Singh Hanuwant
Journal:  Indian J Nucl Med       Date:  2018 Jan-Mar

5.  Ultrasound-Based Scoring System for Indication of Pyeloplasty in Patients With UPJO-Like Hydronephrosis.

Authors:  Bruce Li; Melissa McGrath; Forough Farrokhyar; Luis H Braga
Journal:  Front Pediatr       Date:  2020-07-02       Impact factor: 3.418

Review 6.  Diuresis renography in equivocal urinary tract obstruction. A historical perspective.

Authors:  Girolamo Tartaglione; Danyelle M Townsend; Pier Francesco Bassi; Roberto C Delgado Bolton; Francesco Giammarile; Domenico Rubello
Journal:  Biomed Pharmacother       Date:  2019-05-25       Impact factor: 6.529

7.  Role of ureteric stents in relieving obstruction in patients with obstructive uropathy.

Authors:  M Shehab; A El Helali; M Abdelkhalek; M Abdelshafy; M Mourad; H El Helaly; M Zikry
Journal:  Urol Ann       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.